Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05753202
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-30
First Post:
2023-03-01
Brief Title:
tDCS in Post-COVID Syndrome Comparison of Two Targets
Sponsor:
Hospital San Carlos Madrid
Organization:
Hospital San Carlos Madrid
Study Overview
Official Title:
Neuromodulation Using Transcranial Direct Current Stimulation tDCS in Post-COVID Syndrome Comparison of Two Targets
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main aim of this study is to compare the effect of two non-invasive neuromodulation targets in patients meeting WHO criteria for the post-COVID condition A randomized parallel double-blind study will be conducted Patients will receive 15 neuromodulation sessions through transcranial electrical stimulation for 3 weeks associated with cognitive stimulation during therapy The main objective will be to evaluate the change in physical fatigue As secondary objectives changes in cognition depression pain quality of sleep and quality of life will be evaluated The objective of this study is to evaluate the effect of two targets left dorsolateral prefrontal and M1 of the neuromodulation intervention together with cognitive stimulation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None